LOXL4, but Not LOXL2, Is the Critical Determinant of Pathological Collagen Cross-Linking and Fibrosis in the Lung

Scientists reported that, while its expression was increased in fibrotic lungs, genetic ablation of LOXL2 only led to a modest reduction of pathological collagen cross-linking but not fibrosis in the lung.